著者

山本 武史 山本 和宜 木村 福男 吉田 哲也 山崎 富士子 西村 篤弘 中原 優 内田 豊 石本 敬三 神谷 晃

出版者

一般社団法人日本医療薬学会

雑誌

医療薬学 (ISSN:1346342X)

巻号頁・発行日

vol.27, no.4, pp.406-413, 2001-08-10 (Released:2011-03-04)

参考文献数

8

---

According to the guidelines of Japanese Society of Hospital Pharmacists, pharmacists should prepare medicine bags or labels for dispensing injectable medicines. However, it is not easy to establish a new system for printing these bags and labels quickly and efficiently all hospitals. At the moment many hospitals seem to let nurses write the information by hand directly on the transfusion bottles. This involved the risk of serious accidents due to miscommunication between pharmacists and nurses. Because we established a successful advanced system to achieve a maximum output with a minimum effort, its effectiveness is herein reported. We prepared labels using the data of our audit manual for the dispensing of injectable medicines. These labels included essential comments and information for both doctors and nurses. It takes 60-120 minutes to creating labels for 60 to 90 inpatients, while some additional time is needed to double check of the labels. As a result, this system has increased our workload by one and half times. In contrast to our increased workload, clear printed letters and useful comments and information has contributed to a decrease in the workload of the nurses in the ward. This cost effective, efficient system has received high acclaim from the staff members of other departments, and strongly confirms the role of pharmacists as risk managers. We now intend to further improve this system for proper dispensation of injectable medicines more properly and efficiently in the future.

著者

大坪 泰昭 石本 敬三 谷岡 百恵 内海 敬子 藤本 直子 石光 淳 内田 豊 神谷 晃

出版者

公益社団法人日本薬学会

雑誌

藥學雜誌 (ISSN:00316903)

巻号頁・発行日

vol.122, no.6, pp.389-397, 2002-06-01

被引用文献数

7 6

---

A checking system was developed for risk management of injectable anticancer drug use. Because the dosage and administration of injectable anticancer drugs vary with each patient, checking the prescription and aseptic i.v. admixing can be markedly complicated and time-consuming for pharmacists. The system we investigated in this study provided real-time checking of dosage, drip infusion rate, dosing periods, and dosing-free periods. The prescription parameters for this check included height, weight, body surface area, the medical history of each patient, the patient's ICD10 code' and disease indication from the package insert. Moreover, when preparing for aseptic i.v. admixing, the liquid volume after the anticancer drug has been mixed with other injectable drugs is calculated automatically. The time limits for stability after mixing and clinical laboratory test results are listed on the Work Sheet. As a result, 24 medication errors were prevented in the first 6 months of use of this system. These consisted of over- and under-doses, excessive dosing periods, insufficient dosing-free periods' etc. The time required for preparation of aseptic i.v. admixing decreased by 73% after introducing this system. Because clinical laboratory test results were referenced beforehand, patients to whom the drug should not be administered were recognized in advance. Thus 13 such cases were identified before i.v. admixing. Therefore this system may be useful in terms of rational anticancer drug use and risk management.